Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05679518

Managing Fear of Cancer Progression Metacognition-based Vs Supportive-expressive Based Approaches

Conditions: Advanced or Metastatic Cancer, Fear of Cancer Progression, Metacognition-based Intervention, Supportive-expressive Based Intervention, Psychooncology

Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 261
Sponsor: The University of Hong Kong

Summary

The present study aims to conduct a randomized controlled trial to assess the effect of CALM intervention and ConquerFear intervention on fear of cancer progression among Chinese patients diagnosed with advanced cancer.

Eligibility Criteria

Inclusion Criteria:Cantonese- or Mandarin-speaking Chinese patients recently diagnosed with advanced or metastatic (i.e. stage III or IV) cancerare the age of 18 years or aboveExclusion Criteria:Patients with major communication difficultiesare being unwilling or unable to commit 6 psychotherapy sessions

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05679518). StuddyBuddy aggregates publicly available trial information.